GlassScriptPhysician profile
Christopher J Naismith
NPI 1275984809
$10,400.05
in general payments reported to CMS, 2019-2025
52 companies · $1,946 in 2025
The $1,946 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,045 · 2022: $1,954 · 2023: $1,902 · 2024: $3,554 · 2025: $1,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,830 · Travel and Lodging: $1,279 · Education: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,829.56 |
| Travel and Lodging | $1,279.00 |
| Education | $293.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,094.95 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $1,527.84 | 2021-2025 | Airsupra, Fasenra, Tezspire |
| Jazz Pharmaceuticals INC. | $775.36 | 2021-2025 | |
| Glaxosmithkline, LLC. | $656.48 | 2021-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $456.51 | 2021-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $430.15 | 2022-2025 | Dupixent |
| Harmony Biosciences LLC | $406.43 | 2021-2024 | Wakix |
| Actelion Pharmaceuticals US, INC. | $382.37 | 2021-2025 | Opsumit, Uptravi |
| Amgen INC. | $361.29 | 2021-2025 | Tezspire, Repatha, Tavneos |
| Merck Sharp & Dohme LLC | $286.63 | 2022-2025 | Verquvo, Zerbaxa, Keytruda |
| Takeda Pharmaceuticals U.S.A., INC. | $279.17 | 2021-2025 | Glassia, Cuvitru |
| Genzyme Corporation | $260.07 | 2021-2025 | |
| Grifols USA, LLC | $253.24 | 2021-2024 | Prolastin-C Liquid |
| Philips North America LLC | $226.69 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| United Therapeutics Corporation | $211.22 | 2021-2025 | Tyvaso, Tyvaso |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $197.01 | 2021-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $174.67 | 2021-2022 | |
| Axsome Therapeutics, INC. | $158.50 | 2022-2024 | Sunosi |
| Janssen Pharmaceuticals, INC | $144.98 | 2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $93.83 | 2021-2024 | Onpattro |
| Kiniksa Pharmaceuticals, LTD. | $80.50 | 2021-2023 | Arcalyst |
| Baxter Healthcare | $74.87 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Boston Scientific Corporation | $63.13 | 2024-2025 | Watchman Flx |
| Pulmonx Corporation | $57.11 | 2022-2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Insmed, INC. | $56.03 | 2021-2022 | |
| Abbott Laboratories | $47.53 | 2022-2023 | Cardiomems |
| Amryt Pharma Holdings LTD | $47.10 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.86 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $37.62 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $37.30 | 2023-2024 | Lumryz |
| Pfizer INC. | $37.07 | 2023 | |
| Electromed, INC. | $36.40 | 2022-2025 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $36.39 | 2021 | |
| Novo Nordisk INC | $36.08 | 2023-2024 | Rybelsus, Ozempic |
| Teleflex LLC | $32.19 | 2021 | |
| Bracco Diagnostics INC. | $27.90 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $25.78 | 2024 | Arcalyst |
| Tactile Systems Technology INC | $20.00 | 2024 | |
| Scpharmaceuticals INC. | $19.00 | 2023 | |
| Hospira, INC. | $18.86 | 2024 | |
| Ani Pharmaceuticals, INC. | $18.82 | 2024 | Purified Cortrophin Gel |
| Resmed Corp | $18.48 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.44 | 2023 | Lifevest |
| Esperion Therapeutics, INC. | $18.30 | 2024 | Nexletol |
| 3b Medical, INC. | $17.62 | 2025 | Luna |
| Genentech USA, INC. | $17.21 | 2021 | |
| Lilly USA, LLC | $17.11 | 2025 | Zepbound |
| Csl Behring | $16.57 | 2024 | Hizentra |
| Verona Pharma, INC. | $14.01 | 2025 | Ohtuvayre |
| Eisai INC. | $12.58 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.05 | 2021 | |
| Lundbeck LLC | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Naismith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.